Keywords: amgen, mucositis, drug, clears, phase, iii, trial

Amgen's mucositis drug clears Phase III trial

Article | 03 February 2003

Print This

Amgen's recombinant human keratinocte growth factor has been found todecrease both the duration and incidence of severe oral mucositis in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in